334 related articles for article (PubMed ID: 20664611)
1. Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.
Paterson LM; Tyacke RJ; Nutt DJ; Knudsen GM
J Cereb Blood Flow Metab; 2010 Oct; 30(10):1682-706. PubMed ID: 20664611
[TBL] [Abstract][Full Text] [Related]
2. Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice.
Rice OV; Gatley SJ; Shen J; Huemmer CL; Rogoz R; DeJesus OT; Volkow ND; Gifford AN
Neuropsychopharmacology; 2001 Nov; 25(5):679-89. PubMed ID: 11682251
[TBL] [Abstract][Full Text] [Related]
3. Optimising PET approaches to measuring 5-HT release in human brain.
Tyacke RJ; Nutt DJ
Synapse; 2015 Oct; 69(10):505-11. PubMed ID: 26089243
[TBL] [Abstract][Full Text] [Related]
4. 5-HT radioligands for human brain imaging with PET and SPECT.
Paterson LM; Kornum BR; Nutt DJ; Pike VW; Knudsen GM
Med Res Rev; 2013 Jan; 33(1):54-111. PubMed ID: 21674551
[TBL] [Abstract][Full Text] [Related]
5. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.
Talbot PS; Frankle WG; Hwang DR; Huang Y; Suckow RF; Slifstein M; Abi-Dargham A; Laruelle M
Synapse; 2005 Mar; 55(3):164-75. PubMed ID: 15605360
[TBL] [Abstract][Full Text] [Related]
6. New Trends and Current Status of Positron-Emission Tomography and Single-Photon-Emission Computerized Tomography Radioligands for Neuronal Serotonin Receptors and Serotonin Transporter.
Hazari PP; Pandey A; Chaturvedi S; Mishra AK
Bioconjug Chem; 2017 Nov; 28(11):2647-2672. PubMed ID: 28767225
[TBL] [Abstract][Full Text] [Related]
7. Neuroimaging of serotonin system in anxiety disorders.
Maron E; Nutt D; Shlik J
Curr Pharm Des; 2012; 18(35):5699-708. PubMed ID: 22632475
[TBL] [Abstract][Full Text] [Related]
8. A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System.
Beliveau V; Ganz M; Feng L; Ozenne B; Højgaard L; Fisher PM; Svarer C; Greve DN; Knudsen GM
J Neurosci; 2017 Jan; 37(1):120-128. PubMed ID: 28053035
[TBL] [Abstract][Full Text] [Related]
9. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
Vegting Y; Reneman L; Booij J
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
[TBL] [Abstract][Full Text] [Related]
10. Serotonin: imaging findings in eating disorders.
Bailer UF; Kaye WH
Curr Top Behav Neurosci; 2011; 6():59-79. PubMed ID: 21243470
[TBL] [Abstract][Full Text] [Related]
11. Cerebral 5-HT release correlates with [
Jørgensen LM; Weikop P; Villadsen J; Visnapuu T; Ettrup A; Hansen HD; Baandrup AO; Andersen FL; Bjarkam CR; Thomsen C; Jespersen B; Knudsen GM
J Cereb Blood Flow Metab; 2017 Feb; 37(2):425-434. PubMed ID: 26825776
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.
Lemoine L; Andries J; Le Bars D; Billard T; Zimmer L
J Nucl Med; 2011 Nov; 52(11):1811-8. PubMed ID: 21990574
[TBL] [Abstract][Full Text] [Related]
13. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans.
Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G
J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198
[TBL] [Abstract][Full Text] [Related]
14. Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study.
Frey BN; Rosa-Neto P; Lubarsky S; Diksic M
Neuroimage; 2008 Aug; 42(2):850-7. PubMed ID: 18583156
[TBL] [Abstract][Full Text] [Related]
15. PET tracers for 5-HT(1A) receptors and uses thereof.
Kumar JS; Mann JJ
Drug Discov Today; 2007 Sep; 12(17-18):748-56. PubMed ID: 17826688
[TBL] [Abstract][Full Text] [Related]
16. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
[TBL] [Abstract][Full Text] [Related]
17. Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
Arena JE; Stoessl AJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S47-51. PubMed ID: 26439947
[TBL] [Abstract][Full Text] [Related]
18. Dual-radiotracer translational SPECT neuroimaging. Comparison of three methods for the simultaneous brain imaging of D
Tsartsalis S; Tournier BB; Habiby S; Ben Hamadi M; Barca C; Ginovart N; Millet P
Neuroimage; 2018 Aug; 176():528-540. PubMed ID: 29723640
[TBL] [Abstract][Full Text] [Related]
19. News and views on in-vivo imaging of neurotransmission using PET and MRI.
Sander CY; Hesse S
Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):414-428. PubMed ID: 28750497
[TBL] [Abstract][Full Text] [Related]
20. The structure of the serotonin system: A PET imaging study.
Beliveau V; Ozenne B; Strother S; Greve DN; Svarer C; Knudsen GM; Ganz M
Neuroimage; 2020 Jan; 205():116240. PubMed ID: 31600591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
